This report displays the potential drug interactions for the following 2 drugs:
- Alka-Seltzer Plus Cold Formula Orange Zest Effervescent Tablets (aspirin/chlorpheniramine/phenylephrine)
- protein c
Table of Contents
Interactions between your drugs
No interactions were found between Alka-Seltzer Plus Cold Formula Orange Zest Effervescent Tablets and protein c. This does not necessarily mean no interactions exist. Always consult your healthcare provider.
Alka-Seltzer Plus Cold Formula Orange Zest Effervescent Tablets
A total of
716 drugs
are known to interact with
Alka-Seltzer Plus Cold Formula Orange Zest Effervescent Tablets.
-
Alka-seltzer plus cold formula orange zest effervescent tablets is in the drug class
upper respiratory combinations. - Alka-seltzer plus cold formula orange zest effervescent tablets is used to treat the following conditions:
protein c
A total of
34 drugs
are known to interact with
protein c.
Drug and food interactions
Alcohol can increase the nervous system side effects of chlorpheniramine such as dizziness, drowsiness, and difficulty concentrating. Some people may also experience impairment in thinking and judgment. You should avoid or limit the use of alcohol while being treated with chlorpheniramine. Do not use more than the recommended dose of chlorpheniramine, and avoid activities requiring mental alertness such as driving or operating hazardous machinery until you know how the medication affects you. Talk to your doctor or pharmacist if you have any questions or concerns.
Therapeutic duplication warnings
No warnings were found for your selected drugs.
Therapeutic duplication warnings are only returned when drugs within the same group exceed the recommended therapeutic duplication maximum.
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.